BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36910448)

  • 1. Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer.
    Piver RN; Wagner VM; Levine MD; Backes FJ; Chambers LJ; Cohn DE; Copeland LJ; Cosgrove CM; Nagel CI; O'Malley DM; Bixel KL
    Gynecol Oncol Rep; 2023 Apr; 46():101156. PubMed ID: 36910448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative venous thromboembolism risk stratification in patients with uterine cancer.
    Wagner VM; Piver RN; Levine MD; Backes FJ; Chambers LJ; Cohn DE; Copeland LJ; Cosgrove CM; Nagel CI; O'Malley DM; Bixel KL
    Am J Obstet Gynecol; 2023 May; 228(5):555.e1-555.e8. PubMed ID: 36574873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective Cohort Study of Venous Thromboembolism Rates in Ambulatory Cancer Patients: Association With Khorana Score and Other Risk Factors.
    Austin K; George J; Robinson EJ; Scully M; Thomas MR
    J Hematol; 2019 Mar; 8(1):17-25. PubMed ID: 32300436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification for the development of venous thromboembolism in hospitalized patients with cancer.
    Parker A; Peterson E; Lee AYY; de Wit C; Carrier M; Polley G; Tien J; Wu C
    J Thromb Haemost; 2018 Jul; 16(7):1321-1326. PubMed ID: 29733498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma.
    Sanfilippo KM; Carson KR; Wang TF; Luo S; Edwin N; Kuderer N; Keller JM; Gage BF
    Res Pract Thromb Haemost; 2022 Jan; 6(1):e12634. PubMed ID: 35028491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
    Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S
    Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma.
    Vathiotis I; Dimakakos EP; Boura P; Ntineri A; Charpidou A; Gerotziafas G; Syrigos K
    Clin Appl Thromb Hemost; 2018 Nov; 24(8):1347-1351. PubMed ID: 29806470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism risk in patients receiving neoadjuvant chemotherapy for bladder cancer.
    Garas SN; McAlpine K; Ross J; Carrier M; Bossé D; Yachnin D; Mallick R; Cagiannos I; Morash C; Breau RH; Lavallée LT
    Urol Oncol; 2022 Aug; 40(8):381.e1-381.e7. PubMed ID: 35581123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemotherapy.
    Ramos JD; Casey MF; Bamias A; De Giorgi U; Bellmunt J; Harshman LC; Ladoire S; Wong YN; Alva AS; Rosenberg JE; Galsky MD; Yu EY;
    Clin Appl Thromb Hemost; 2017 Oct; 23(7):755-760. PubMed ID: 27637910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer.
    Li S; Gao P; Qiu J; He X; Mao Y
    J Thromb Thrombolysis; 2021 Oct; 52(3):898-903. PubMed ID: 33599857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy.
    Overvad TF; Ording AG; Nielsen PB; Skjøth F; Albertsen IE; Noble S; Vistisen AK; Gade IL; Severinsen MT; Piazza G; Larsen TB
    Blood Adv; 2022 May; 6(10):2967-2976. PubMed ID: 35045569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PO-03 - Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL).
    Santi RM; Ceccarelli M; Catania G; Monagheddu C; Evangelista A; Bernocco E; Monaco F; Federico M; Vitolo U; Cortelazzo S; Cabras MG; Spina M; Baldini L; Boccomini C; Chiappella A; Bari A; Luminari S; Calabrese M; Levis A; Visco C; Contino L; Ciccone G; Ladetto M
    Thromb Res; 2016 Apr; 140 Suppl 1():S177. PubMed ID: 27161692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts.
    Muñoz A; Ay C; Grilz E; López S; Font C; Pachón V; Castellón V; Martínez-Marín V; Salgado M; Martínez E; Calzas J; Ortega L; Rupérez A; Salas E; Pabinger I; Soria JM
    J Clin Oncol; 2023 Jun; 41(16):2911-2925. PubMed ID: 36730884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis.
    van Es N; Ventresca M; Di Nisio M; Zhou Q; Noble S; Crowther M; Briel M; Garcia D; Lyman GH; Macbeth F; Griffiths G; Iorio A; Mbuagbaw L; Neumann I; Brozek J; Guyatt G; Streiff MB; Baldeh T; Florez ID; Gurunlu Alma O; Agnelli G; Ageno W; Marcucci M; Bozas G; Zulian G; Maraveyas A; Lebeau B; Lecumberri R; Sideras K; Loprinzi C; McBane R; Pelzer U; Riess H; Solh Z; Perry J; Kahale LA; Bossuyt PM; Klerk C; Büller HR; Akl EA; Schünemann HJ;
    J Thromb Haemost; 2020 Aug; 18(8):1940-1951. PubMed ID: 32336010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapy.
    Srikanthan A; Tran B; Beausoleil M; Jewett MA; Hamilton RJ; Sturgeon JF; O'Malley M; Anson-Cartwright L; Chung PW; Warde PR; Winquist E; Moore MJ; Amir E; Bedard PL
    J Clin Oncol; 2015 Feb; 33(6):582-7. PubMed ID: 25605848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of a Modified Khorana Score for Predicting Venous Thromboembolism in Newly Diagnosed Stage IV Lung Cancer.
    Qin Y; Liang X; Wu H; Sun X; Yan S; Wang N; Yuan M; Wang Q; Wu D
    Angiology; 2023 Nov; ():33197231213197. PubMed ID: 37924222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data.
    Tsubata Y; Kawakado K; Hamai K; Furuya N; Yokoyama T; Saito R; Nakamura A; Masuda T; Hamaguchi M; Kuyama S; Honda R; Senoo T; Nakanishi M; Hotta T; Yamasaki M; Ishikawa N; Fujitaka K; Kubota T; Kobayashi K; Isobe T
    Int J Clin Oncol; 2023 Jan; 28(1):69-78. PubMed ID: 36357710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with metastatic pancreatic cancer: a retrospective study.
    Kim JS; Kang EJ; Kim DS; Choi YJ; Lee SY; Kim HJ; Seo HY; Kim JS
    BMC Cancer; 2018 Dec; 18(1):1260. PubMed ID: 30558603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of venous thromboembolism in cancer patients receiving chemotherapy: a meta-analysis with systematic review.
    Bao Y; Wan X; Fu J; Wu B
    Ann Transl Med; 2021 Feb; 9(4):277. PubMed ID: 33708904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PO-04 - A new genetic risk score for predicting venous thromboembolic events in cancer patients receiving chemotherapy.
    Martín AJ; Ziyatdinov A; Rubio VC; Olmos VP; Huerta BM; Rodríguez JC; Fernández MS; de Castro EM; Caro RL; Fernández JM
    Thromb Res; 2016 Apr; 140 Suppl 1():S177-8. PubMed ID: 27161691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.